Invention Grant
- Patent Title: RVG Derived peptides
-
Application No.: US15549031Application Date: 2015-02-04
-
Publication No.: US10548984B2Publication Date: 2020-02-04
- Inventor: Omar M. Ali El-Agnaf
- Applicant: United Arab Emirates University
- Applicant Address: AE Al Ain
- Assignee: United Arab Emirates University
- Current Assignee: United Arab Emirates University
- Current Assignee Address: AE Al Ain
- Agency: Fitch, Even, Tabin & Flannery, LLP
- International Application: PCT/IB2015/050846 WO 20150204
- International Announcement: WO2016/124976 WO 20160811
- Main IPC: A61K47/64
- IPC: A61K47/64 ; A61K31/713 ; C07K14/005 ; C12N7/00
Abstract:
The invention relates to short RVG derived peptides for use in delivering therapeutic agents across the blood brain barrier and to target cells, for example those cells in the central nervous system. The invention provides method and compositions to treat diseases, such as neurodegenerative diseases, with therapeutic agents associated with targeting peptides.
Public/Granted literature
- US20180028675A1 RVG DERIVED PEPTIDES Public/Granted day:2018-02-01
Information query
IPC分类:
